DE69737329D1 - Synthetische biepitopische zusammensetzungen zur verwendung als kalibratoren bei der biologischen bestimmung von troponin i - Google Patents

Synthetische biepitopische zusammensetzungen zur verwendung als kalibratoren bei der biologischen bestimmung von troponin i

Info

Publication number
DE69737329D1
DE69737329D1 DE69737329T DE69737329T DE69737329D1 DE 69737329 D1 DE69737329 D1 DE 69737329D1 DE 69737329 T DE69737329 T DE 69737329T DE 69737329 T DE69737329 T DE 69737329T DE 69737329 D1 DE69737329 D1 DE 69737329D1
Authority
DE
Germany
Prior art keywords
troponin
compositions
synthetic
biepitopian
calibrators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69737329T
Other languages
English (en)
Other versions
DE69737329T2 (de
Inventor
Noelle Babin
Didier Calzolari
Suzanne Flecheux
Claude Granier
Christiane Larue
Christian Pau
Yves Rieunier
Marie-France Trinquier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Rad Innovations SAS
Original Assignee
Bio Rad Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Pasteur SA filed Critical Bio Rad Pasteur SA
Application granted granted Critical
Publication of DE69737329D1 publication Critical patent/DE69737329D1/de
Publication of DE69737329T2 publication Critical patent/DE69737329T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/967—Standards, controls, materials, e.g. validation studies, buffer systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69737329T 1996-12-05 1997-12-04 Synthetische biepitopische zusammensetzungen zur verwendung als kalibratoren bei der biologischen bestimmung von troponin i Expired - Lifetime DE69737329T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9614959A FR2756827B1 (fr) 1996-12-05 1996-12-05 Composes synthetiques biepitopiques utilisables comme etalons dans les dosages biologiques de la troponine i
FR9614959 1996-12-05
PCT/FR1997/002209 WO1998024816A1 (fr) 1996-12-05 1997-12-04 Composes synthetiques biepitopiques utilisables comme etalons dans les dosages biologiques de la troponine i

Publications (2)

Publication Number Publication Date
DE69737329D1 true DE69737329D1 (de) 2007-03-22
DE69737329T2 DE69737329T2 (de) 2007-06-28

Family

ID=9498377

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69737329T Expired - Lifetime DE69737329T2 (de) 1996-12-05 1997-12-04 Synthetische biepitopische zusammensetzungen zur verwendung als kalibratoren bei der biologischen bestimmung von troponin i

Country Status (11)

Country Link
US (1) US6867011B1 (de)
EP (1) EP0964871B1 (de)
JP (2) JP3843136B2 (de)
AT (1) ATE353338T1 (de)
AU (1) AU735873B2 (de)
CA (1) CA2274303C (de)
DE (1) DE69737329T2 (de)
ES (1) ES2283031T3 (de)
FR (1) FR2756827B1 (de)
WO (1) WO1998024816A1 (de)
ZA (1) ZA9710964B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6531316B1 (en) 1999-03-05 2003-03-11 Maxyag, Inc. Encryption of traits using split gene sequences and engineered genetic elements
FR2797689B1 (fr) * 1999-08-16 2003-06-27 Pasteur Sanofi Diagnostics Utilisation de composes synthetiques pour des immunodosages
US7858747B2 (en) * 2005-08-30 2010-12-28 Novo Nordisk A/S Expression of proteins in E.coli
US20110306148A1 (en) 2010-06-14 2011-12-15 Siemens Healthcare Diagnostics Inc. Composition for use as an assay reagent
US8603760B2 (en) 2011-12-20 2013-12-10 Panasonic Corporation Recombinant protein capable of binding specifically and quickly to troponin I derived from human myocardium
JPWO2013094080A1 (ja) * 2011-12-20 2015-04-27 パナソニックヘルスケア株式会社 ヒト心筋由来トロポニンｉに特異的にかつ速やかに結合できる組み換えタンパク質
JPWO2013099043A1 (ja) * 2011-12-26 2015-04-30 パナソニックヘルスケア株式会社 ヒト心筋由来トロポニンｉに特異的にかつ速やかに結合できる組み換えタンパク質
JP6385245B2 (ja) * 2014-11-04 2018-09-05 Ｎｉｓｓｈａ株式会社 検出装置及び検出方法
WO2016097613A1 (fr) * 2014-12-18 2016-06-23 bioMérieux Composé synthétique biépitopique

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4243648A1 (de) * 1992-12-23 1994-07-07 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Herzmuskelnekrosen mittels Antikörper gegen das N-terminale Troponin I-Peptid
DE69420556T2 (de) * 1993-05-17 2000-03-23 Fortron Bioscience Inc Assay für troponin i aus dem herzmuskel
DE4420742A1 (de) * 1993-10-20 1995-04-27 Boehringer Mannheim Gmbh Synthetischer Standard für Immunoassays
US6165981A (en) * 1995-03-07 2000-12-26 Dade Behring Inc. Stabilizing solutions for proteins and peptides
DE19524572A1 (de) * 1995-07-06 1997-01-09 Bayer Ag Verfahren zur Herstellung eines synthetischen Kalibrators für den Einsatz in Immunoassays, bestehend aus den Analyten oder Teilsequenzen davon, die an inerten Trägermoleküle konjugiert sind
WO1997039132A1 (en) * 1996-04-16 1997-10-23 University Of Miami Stabilized preparations of human troponins and modifications thereof, diagnostic assay methods and assay kits
EP0946198B1 (de) * 1996-10-15 2002-06-19 Medical Analysis Systems, Inc. Verfahren zur Stabilisierung von Troponin I (CTnI) durch Konjugation mit einem activen Polymer
US6077676A (en) * 1997-12-18 2000-06-20 Spectral Diagnostics, Inc. Single-chain polypeptides comprising troponin I and troponin C

Also Published As

Publication number Publication date
JP2001505571A (ja) 2001-04-24
US6867011B1 (en) 2005-03-15
FR2756827A1 (fr) 1998-06-12
EP0964871B1 (de) 2007-02-07
AU5326198A (en) 1998-06-29
ATE353338T1 (de) 2007-02-15
JP2006036782A (ja) 2006-02-09
FR2756827B1 (fr) 1999-01-29
CA2274303A1 (fr) 1998-06-11
ZA9710964B (en) 1999-06-07
JP3843136B2 (ja) 2006-11-08
DE69737329T2 (de) 2007-06-28
CA2274303C (fr) 2012-01-31
AU735873B2 (en) 2001-07-19
EP0964871A1 (de) 1999-12-22
ES2283031T3 (es) 2007-10-16
WO1998024816A1 (fr) 1998-06-11

Similar Documents

Publication Publication Date Title
DE60019111D1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
ATE278805T1 (de) Verfahren zur quantifizierung von cholesterol in lipoproteinen und quantifizierungsreagenzien
ATE414783T1 (de) Verfahren zur isolierung von stammzellen
AR008919A1 (es) Anticuerpos anti-cd11a humanizados.
DE69429192D1 (de) Ein verfahren zur bestimmung von kollagenfragmenten in körperflüssigkeiten, ein testkit und mittel zur durchführung des verfahrens, und seine verwendung zur feststellung von mit dem kollagenmetabolismus assoziierten störungen
DE69723860D1 (de) VERFAHREN ZUR BESTIMMUNG VON IgE
DE60232234D1 (de) Verfahren zur kultivierung von circovirus
ES2097747T3 (es) Molecula de adhesion intercelular 2 y sus ligandos de union.
DE69837015D1 (de) Verfahren zur Stabilisierung und Messung von Troponinkomplexen
ATE144840T1 (de) Homogene immunotests unter verwendung von enzym- inhibitoren
ATE353338T1 (de) Synthetische biepitopische zusammensetzungen zur verwendung als kalibratoren bei der biologischen bestimmung von troponin i
DE68917438D1 (de) Durch die Verwendung von Substraten, deren Fluoreszenzeigenschaften sich von denen der umgewandelten Produkte unterscheiden, gekennzeichnete Methode zur Bestimmung der Enzymaktivität.
ATE115728T1 (de) Verfahren zur verminderung von störungen in einer fluoreszenzbestimmung.
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
DE59508474D1 (de) RHEUMAFAKTOR-ENTSTÖRUNG MIT ANTI-Fd-ANTIKÖRPERN
ATE221657T1 (de) Entstörung durch rheumafaktoren
DE3776525D1 (de) Immunochemisches verfahren zur bestimmung von stabilem glykosiliertem haemoglobin.
DE69704328T2 (de) Verfahren zur quantitativen Bestimmung von 1,5-Anhydroglucitol, sowie Reagenz zur quantitativen Bestimmung
DE3789087D1 (de) Verfahren zur Bestimmung von Anti-HIV, Mittel dazu und ihre Verwendung in diesem Verfahren.
DE69819833D1 (de) Verfahren und Teststreife zur Veringerung des Harnstoffeinflusses bei immunochromatographischen Messungen unter Verwendung von Urinproben
PT82940A (de) Mit uberzugen versehene formkorper zur bindung von bioaffinen substanzen verfahren zu ihrer herstellung sowie ihre verwendung
ATE208502T1 (de) Reagenzien und verfahren zur detektion und quantitativen bestimmung von testosteron in flüssigen proben
WO1998029726A3 (en) Method of detecting and determining the concentration of total troponin i in a biological sample
ATE222954T1 (de) Verfahren zur herstellung von dem anaphase- fördernden komplex
WO2004078783A3 (en) Enzymes involved in apoptosis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition